1. Home
  2. MLEC vs HKPD Comparison

MLEC vs HKPD Comparison

Compare MLEC & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$7.86

Market Cap

6.5M

Sector

Finance

ML Signal

HOLD

HKPD

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

N/A

Current Price

$0.53

Market Cap

6.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MLEC
HKPD
Founded
2008
2016
Country
Cayman Islands
Hong Kong
Employees
72
27
Industry
Blank Checks
Other Pharmaceuticals
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MLEC
HKPD
Price
$7.86
$0.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.5K
84.2K
Earning Date
05-12-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.42
N/A
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.37
52 Week High
$23.22
$2.74

Technical Indicators

Market Signals
Indicator
MLEC
HKPD
Relative Strength Index (RSI) 46.48 37.04
Support Level $7.18 $0.45
Resistance Level $11.48 $0.71
Average True Range (ATR) 0.85 0.07
MACD -0.12 -0.01
Stochastic Oscillator 14.34 29.67

Price Performance

Historical Comparison
MLEC
HKPD

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

Share on Social Networks: